Estimate Recalculated Nov 11, 2024 01:35PM EST
Braslyn Ltd. has an estimated net worth of $344 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Tango Therapeutics, Inc., INSEEGO CORP., Esperion Therapeutics, Inc., Solid Biosciences Inc., and Pandion Therapeutics Holdco LLC.
Braslyn Ltd.'s CIK is 0001642355
2017 was Braslyn Ltd.'s most active year for acquiring shares with 13 total transactions. Braslyn Ltd.'s most active month to acquire stocks was the month of December. 2020 was Braslyn Ltd.'s most active year for disposing of shares, totalling 41 transactions. Braslyn Ltd.'s most active month to dispose stocks was the month of September. 2017 saw Braslyn Ltd. paying a total of $32,169,808.18 for 5,754,047 shares, this is the most they've acquired in one year. In 2020 Braslyn Ltd. cashed out on 5,597,581 shares for a total of $228,777,517.36, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!